Sanarus Technologies
Encyclopedia
Sanarus Technologies is a medical device company that develops and markets minimally-invasive, office-based breast care diagnosis and treatment solutions to patients and physicians. The company provides cryoablation technology that is used to freeze tissue for diagnostic and therapeutic breast care procedures. In July 2009, the company purchased the assets of Sanarus Medical, Inc.
The company was originally founded in 1999 and is headquartered in Pleasanton
, California
.
The company was originally founded in 1999 and is headquartered in Pleasanton
Pleasanton, California
Pleasanton is a city in Alameda County, California, incorporated in 1894. It is a suburb in the San Francisco Bay Area located about east of Oakland, and west of Livermore. The population was 70,285 at the 2010 census. In 2005 and 2007, Pleasanton was ranked the wealthiest middle-sized city in...
, California
California
California is a state located on the West Coast of the United States. It is by far the most populous U.S. state, and the third-largest by land area...
.
Product Offerings
- Visica 2 Treatment System uses cryoablationCryoablationCryoablation is a process that uses extreme cold to remove tissue .Cryoablation is used in a variety of clinical applications using hollow needles through which cooled, thermally conductive, fluids are circulated...
to treat biopsy proven fibroadenomaFibroadenomaFibroadenomas of the breast, are lumps composed of fibrous and glandular tissue. Because breast cancer can also appear as a lump, doctors may recommend a tissue sample to rule out cancer in older patients...
s and is currently in a Phase 2 clinical trial for the treatment of breast cancerBreast cancerBreast cancer is cancer originating from breast tissue, most commonly from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are known as lobular carcinomas...
.- In 2008, the Visica 2 Treatment System was named a runner-up in the Medical Device category at the Wall Street Journal's Technology Innovation Awards.
- In 2008, the American College of Surgeons Oncology GroupAmerican College of Surgeons Oncology GroupThe American College of Surgeons Oncology Group is a clinical trial cooperative group supported publicly by the National Cancer Institute . Established during the 1990s, ACOSOG has a different mission when compared to other cooperative groups. For the most part, ACOSOG focuses on the effects of...
chose the Visica 2TM Treatment System as the exclusive ablationAblationAblation is removal of material from the surface of an object by vaporization, chipping, or other erosive processes. This occurs in spaceflight during ascent and atmospheric reentry, glaciology, medicine, and passive fire protection.-Spaceflight:...
treatment technology for a National Cancer InstituteNational Cancer InstituteThe National Cancer Institute is part of the National Institutes of Health , which is one of 11 agencies that are part of the U.S. Department of Health and Human Services. The NCI coordinates the U.S...
funded study to explore the success of cryoablation therapy in the treatment of Invasive Breast Carcinoma.
- Cassi II Rotational Core Biopsy System is a hand-held and self-contained breast biopsy device that utilizes cryotechnology.
- ImarC Tissue Marker System is a breast tissue marking system that is capable of long-term visibility under X-ray, Ultrasound and MRI.